QQ客服 官方微博 反馈留言

	Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway
	Zhang, Zhiguo; Wang, Shudong; Zhou, Shanshan; Yan, Xiaoqing; Wang, Yonggang; Mellen, Nicholas; Kong, Maiying; Gu, Junlian; Tan, Yi; Geng D(更多)
刊名	JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
	2014
卷号	77页码:42-52
关键词	Sulforaphane Type 2 diabetes Cardiomyopathy Oxidative stress LKB1/AMPK pathway Cardiac lipotoxicity
DOI	10.1016/j.yjmcc.2014.09.022
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4797445
专题	山东大学
作者单位	1.Jilin Univ, Hosp 1, Dept Cardiol, Changchun 130023, Peoples R China. 2.[Z
推荐引用方式 GB/T 7714	Zhang, Zhiguo,Wang, Shudong,Zhou, Shanshan,et al. Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway[J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY,2014,77:42-52.
APA	Zhang, Zhiguo.,Wang, Shudong.,Zhou, Shanshan.,Yan, Xiaoqing.,Wang, Yonggang.,...&Geng D.(2014).Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY,77,42-52.
MLA	Zhang, Zhiguo,et al."Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway".JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 77(2014):42-52.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。